Suppr超能文献

相似文献

2
First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Induced CL in Sri Lanka.
Biomed Res Int. 2020 Sep 29;2020:5271657. doi: 10.1155/2020/5271657. eCollection 2020.
3
Clinical and epidemiological studies on the cutaneous leishmaniasis caused by Leishmania (Leishmania) donovani in Sri Lanka.
Ann Trop Med Parasitol. 2010 Apr;104(3):213-23. doi: 10.1179/136485910X12647085215615.
4
Serological studies on rK39 negative Visceral Leishmaniasis in an endemic focus of Leishmania donovani induced Cutaneous Leishmaniasis.
Diagn Microbiol Infect Dis. 2023 Mar;105(3):115873. doi: 10.1016/j.diagmicrobio.2022.115873. Epub 2022 Nov 24.
5
Measuring the sero-prevalence of Leishmania donovani induced cutaneous leishmaniasis: A method comparison study.
Parasitol Int. 2023 Feb;92:102660. doi: 10.1016/j.parint.2022.102660. Epub 2022 Aug 28.
6
Efficacy of a new rapid diagnostic test kit to diagnose Sri Lankan cutaneous leishmaniasis caused by Leishmania donovani.
PLoS One. 2017 Nov 14;12(11):e0187024. doi: 10.1371/journal.pone.0187024. eCollection 2017.
7
Evidence for Seroprevalence in Human Localized Cutaneous Leishmaniasis Caused by in Sri Lanka.
Biomed Res Int. 2018 Jan 17;2018:9320367. doi: 10.1155/2018/9320367. eCollection 2018.
10
Clinical and epidemiological characteristics of cutaneous leishmaniasis in Sri Lanka.
BMC Infect Dis. 2018 Mar 6;18(1):108. doi: 10.1186/s12879-018-2999-7.

本文引用的文献

1
Humoral response in Leishmaniasis.
Front Cell Infect Microbiol. 2022 Dec 12;12:1063291. doi: 10.3389/fcimb.2022.1063291. eCollection 2022.
2
ELISA-based evaluation of antibody response to Leishmania in a region endemic for cutaneous leishmaniasis.
Parasite Immunol. 2022 Sep;44(9):e12940. doi: 10.1111/pim.12940. Epub 2022 Aug 3.
4
Treatment failure to sodium stibogluconate in cutaneous leishmaniasis: A challenge to infection control and disease elimination.
PLoS One. 2021 Oct 22;16(10):e0259009. doi: 10.1371/journal.pone.0259009. eCollection 2021.
5
Spatiotemporal distribution of cutaneous leishmaniasis in Sri Lanka and future case burden estimates.
PLoS Negl Trop Dis. 2021 Apr 23;15(4):e0009346. doi: 10.1371/journal.pntd.0009346. eCollection 2021 Apr.
6
First Serological Study Revealing High Humoral Response and Evidence for Antigenic Heterogeneity in Induced CL in Sri Lanka.
Biomed Res Int. 2020 Sep 29;2020:5271657. doi: 10.1155/2020/5271657. eCollection 2020.
7
Spatial Epidemiologic Trends and Hotspots of Leishmaniasis, Sri Lanka, 2001-2018.
Emerg Infect Dis. 2020 Jan;26(1):1-10. doi: 10.3201/eid2601.190971.
9
Editorial: Biomarkers in Leishmaniasis.
Front Cell Infect Microbiol. 2019 Nov 12;9:388. doi: 10.3389/fcimb.2019.00388. eCollection 2019.
10
Trends in Recently Emerged Induced Cutaneous Leishmaniasis, Sri Lanka, for the First 13 Years.
Biomed Res Int. 2019 Apr 14;2019:4093603. doi: 10.1155/2019/4093603. eCollection 2019.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验